Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis E | 3 | 2019 | 319 | 0.83 | Why? |
| Jaundice | 1 | 2019 | 114 | 0.70 | Why? |
| Social Medicine | 1 | 2016 | 27 | 0.66 | Why? |
| Databases as Topic | 1 | 2016 | 103 | 0.63 | Why? |
| France | 8 | 2021 | 12074 | 0.49 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.42 | Why? |
| Epidemics | 3 | 2021 | 6407 | 0.42 | Why? |
| Medical Informatics | 1 | 2016 | 648 | 0.38 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.21 | Why? |
| Photopheresis | 1 | 2018 | 33 | 0.19 | Why? |
| Hepatitis Antibodies | 1 | 2019 | 100 | 0.18 | Why? |
| Hepatitis E virus | 2 | 2019 | 306 | 0.18 | Why? |
| Burkina Faso | 1 | 2019 | 302 | 0.18 | Why? |
| Lichenoid Eruptions | 1 | 2018 | 22 | 0.18 | Why? |
| Epidemiologic Methods | 1 | 2021 | 392 | 0.17 | Why? |
| Forensic Sciences | 1 | 2016 | 49 | 0.16 | Why? |
| False Positive Reactions | 1 | 2021 | 1338 | 0.15 | Why? |
| Picornaviridae Infections | 1 | 2021 | 544 | 0.15 | Why? |
| Communicable Disease Control | 3 | 2021 | 29620 | 0.14 | Why? |
| Mouth Diseases | 1 | 2018 | 193 | 0.14 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.14 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.13 | Why? |
| Graft vs Host Disease | 1 | 2018 | 501 | 0.13 | Why? |
| Public Health | 4 | 2021 | 16359 | 0.13 | Why? |
| Models, Statistical | 2 | 2021 | 5312 | 0.12 | Why? |
| Ribavirin | 1 | 2019 | 1182 | 0.12 | Why? |
| Lung | 1 | 2021 | 31049 | 0.12 | Why? |
| Humans | 20 | 2021 | 930598 | 0.11 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2021 | 1234 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Saliva | 2 | 2021 | 4679 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.09 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.08 | Why? |
| Skin | 1 | 2018 | 2096 | 0.08 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.07 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.07 | Why? |
| Transplant Recipients | 1 | 2019 | 4982 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2019 | 9091 | 0.06 | Why? |
| Adult | 6 | 2021 | 244371 | 0.05 | Why? |
| Child | 2 | 2021 | 70012 | 0.05 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.05 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.05 | Why? |
| Hepatitis, Chronic | 1 | 2019 | 53 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.05 | Why? |
| Nervous System Diseases | 1 | 2018 | 4092 | 0.05 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.05 | Why? |
| Sclerosis | 1 | 2018 | 26 | 0.05 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.05 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.05 | Why? |
| Male | 6 | 2021 | 367725 | 0.04 | Why? |
| Female | 6 | 2021 | 380317 | 0.04 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.04 | Why? |
| Foodborne Diseases | 1 | 2018 | 89 | 0.04 | Why? |
| Sustained Virologic Response | 1 | 2019 | 378 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Mycophenolic Acid | 1 | 2018 | 383 | 0.04 | Why? |
| Tacrolimus | 1 | 2018 | 435 | 0.04 | Why? |
| Mouth Mucosa | 1 | 2018 | 323 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2019 | 21571 | 0.04 | Why? |
| Cyclosporine | 1 | 2018 | 449 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.03 | Why? |
| Prednisone | 1 | 2018 | 652 | 0.03 | Why? |
| Treatment Failure | 1 | 2019 | 2106 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Kinetics | 1 | 2019 | 3238 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.03 | Why? |
| Aged | 3 | 2021 | 215776 | 0.02 | Why? |
| Plasma | 1 | 2019 | 1809 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.02 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.02 | Why? |
| Antiviral Agents | 1 | 2019 | 41703 | 0.02 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 2426 | 0.02 | Why? |
| Organ Transplantation | 1 | 2019 | 2616 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Occupational Exposure | 1 | 2018 | 4742 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Virus Replication | 1 | 2019 | 14331 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Dimeglio's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_